Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
Open Access
- 19 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (3), 920-923
- https://doi.org/10.1038/s41375-021-01175-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tractCellular & Molecular Immunology, 2020
- Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the NetherlandsLeukemia, 2020
- Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemiaLeukemia, 2020
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patientsScience, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020
- Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseasesLeukemia, 2020
- Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2Journal of Medical Virology, 2020
- viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemiaNature Biotechnology, 2013
- Moderate mutation rate in the SARS coronavirus genome and its implicationsBMC Evolutionary Biology, 2004